JNJ-64565111 Dose Level 2
Sponsors
Janssen Research & Development, LLC
Conditions
ObesityObesity and Diabetes Mellitus, Type 2
Phase 2
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
CompletedNCT03486392
Start: 2018-03-26End: 2019-03-08Updated: 2020-02-05
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
CompletedNCT03586830
Start: 2018-06-26End: 2019-04-05Updated: 2020-01-07